CancerConnect Announces Milestone for Non-Hodgkin’s Lymphoma Web Chat with the Expert

CancerConnect Announces Milestone for Non-Hodgkin’s Lymphoma Web Chat with the Expert

Sun Valley, Idaho and Fort Worth, Texas – CancerConnect announces new milestone of over 6,000 views for nationally recognized Ask the Expert Series in a recent Web Chat with Memorial Sloan Kettering Cancer Center Expert expert, Steven M. Horwitz, MD. You can access the archived version of the Web Chat here. In this popular Web chat, Dr. Horwitz discussed and answered participants’ questions about non-Hodgkin’s lymphoma (NHL). Topics included:

  • Features of these diseases
  • Advances in diagnosis
  • Prognostic tools available to better select treatments for patients most likely to respond
  • New treatments, new drug combinations, and ways to make therapy more effective
  • On the horizon: clinical trials and vaccines
  • Survivorship and quality of life

LymphomaDr. Horwitz is a medical oncologist specializing in lymphoma at Memorial Sloan-Kettering Cancer Center. His research is aimed at developing an improved understanding of new therapies for patients with lymphoma, including T cell lymphomas, cutaneous (skin) lymphomas, Hodgkin lymphoma and others. Click here for Dr. Horwitz’s biography.

The majority of lymphomas can be effectively treated and optimal treatment of lymphoma may consist of chemotherapy, radiation, stem cell transplant, targeted therapies, or radio-immunotherapy used alone or in combination. The type of treatment used is determined by the type (histologic diagnosis) and stage of the lymphoma. Understanding standard treatment options and how and when to access new and innovative therapies available through clinical trials is essential in order to achieve the best outcome.

About CancerConnect: is the leading social network for cancer patients, their friends, and family. This unique online application was developed by OMNI Health Media and combines a robust information platform consisting of current comprehensive information on cancer with a social network. It is populated with rich content to support the many ongoing needs of individuals battling cancer and is comprised of communities of individuals with similar interests in the area of cancer. The CancerConnect application is also available as a fully functional “private label” social network for people with cancer, their caregivers, and others who are interested in staying up-to-date about the set of diseases known as cancer. CancerConnect is used by Dana-Farber Cancer Institute, Memorial Sloan-Kettering Cancer Center, Roswell Park Cancer Inst., The Ohio State James Cancer Inst., the Seattle Cancer Care Alliance, other leading centers and more recently Oncology Clinics including Dayton Physicians and Jackson Oncology. Learn more about how CancerConnect is making a difference in this recent blog by Memorial Sloan-Kettering Cancer Center. CancerConnect is licensed to hospitals and cancer clinics to enhance their Web sites, improve SEO, and allow cancer patients to be part of a social community without leaving the clinic. Disease-specific groups, as well as groups focused on care giving, health and wellness, and nutrition all exist to provide support for anyone affected by a diagnosis of cancer.

About NHL on CancerConnect: Knowledge is power. Are you facing a new diagnosis, recurrence, living with cancer, or supporting a loved one through their cancer journey?

  • Sign up for monthly newsletters on Non-Hodgkin’s Lymphoma here.
  • Get the facts about NHL here.
  • Join the CancerConnect NHL online support group here.
  • Check out our new lymphoma blog here.

About the Web Chat with the Expert Series: The CancerConnect Ask the Expert series is a live online patient education program that encourages interactive discussions with thought leaders in oncology to help facilitate informed treatment decision-making and encourage interaction and engagement within the CancerConnect community. The series includes multimedia formats to meet the needs of patients, caregivers, and others affected by cancer, including the following:

  • One-hour live Web chat programs featuring expert presentations and Q&A sessions
  • 2 to3 day Q&A sessions with oncology experts in the CancerConnect community

The CancerConnect Ask the Expert series impacts thousands of patients and caregivers in their search for quality online information. The series topic and expert moderator are promoted through the CancerConnect community, which currently includes thousands of patients, as well as through all social media outlets. In addition to providing invaluable expert insight for patients and caregivers, the series provides an opportunity for cancer centers to increase visibility of their programs and resources and engage their community. The Ask the Expert programs are archived on Cancer Connect and are promoted through OMNI Health Media social media channels for one year. In 2013 there were seven programs in the Ask the Expert series, and the series has reached over 12,000 individuals affected by cancer. To learn more about Ask the Expert series program participation or sponsorship opportunities, contact Charles Weaver, MD ( or Meg Monday (

About OMNI Health Media: OMNI Health Media is a leading specialty publisher of health-related information with an emphasis on cancer, and on line applications and websites specifically for consumers. Established in 1996, OMNI develops and distributes multi-media health education content and programming, with an emphasis on cancer and women’s health. OMNI has developed over 200 websites and supplies educational content and programming to over 2700 physicians for use on cancer center and clinic websites, including OMNI’s award-wining content programs reach over 1 million seekers of cancer information in English, Japanese, and Spanish each month.